✦ LIBER ✦

Gaucher disease: Enzyme therapy in the acute neuronopathic variant

✍ Scribed by Prows, Cynthia A.; Sanchez, Nelson; Daugherty, Cynthia; Grabowski, Gregory A.

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 23 KB
Volume: 71
Category: Article
ISSN: 0148-7299
DOI: 10.1002/(sici)1096-8628(19970711)71:1<16::aid-ajmg3>3.0.co;2-o

No coin nor oath required. For personal study only.

✦ Synopsis

The responses to regular intravenous enzyme infusions were compared in two sibs with Gaucher disease type 2, the acute neuronopathic variant. Enzyme administration was begun at 7 months in patient 1 who had severe progressive visceral and neuronopathic disease. No significant effect of enzyme infusions was noted. Death occurred at 9 months. Patient 2 was prenatally diagnosed and enzyme infusions were initiated at age 4 days. Overall development progressed at a rate similar to her unaffected full sib until her death at 15.1 months. Slowly progressive esotropia, ocular paresis and dysphagia began at 8 months as did infiltrative pulmonary disease. Comparison of these clinical courses show significant visceral and neurologic effects of anticipatory enzyme therapy, but with unaltered outcome, for Gaucher disease type 2. Am.

📜 SIMILAR VOLUMES

Glucocerebrosidase mutations among chine

Glucocerebrosidase mutations among chinese neuronopathic and non-neuronopathic Gaucher disease patients

✍ Choy, Francis Y.M.; Wong, Karen; Shi, HuiPing 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 20 KB 👁 2 views

## To the Editor: Gaucher disease results from an inherited deficiency of the lysosomal enzyme glucocerebrosidase . Three clinical forms of Gaucher disease have been described: type 1, non-neuronopathic; type 2, acute neuronopathic; and type 3, subacute neuronopathic. Type I Gaucher disease is the

The Táin

✍ Kinsella, Thomas; Kinsella, Thomas ; 📂 Fiction 📅 2002 🏛 Oxford University Press, Incorporated 🌐 English ⚖ 536 KB 👁 1 views

Intrafamilial phenotypic variability in

Intrafamilial phenotypic variability in Engelmann disease (ED): Are ED and Ribbing disease the same entity?

✍ Makita, Yoshio; Nishimura, Gen; Ikegawa, Shiro; Ishii, Takuma; Ito, Yoshiya; Oku 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 1 views

We report on clinical and radiologic manifestations in a 3 -generation Japanese family with Engelmann disease (ED) or progressive diaphyseal dysplasia. A large variation of phenotype was remarkable among 12 affected family members. Of the 12 patients, 7 had full manifestations of ED, such as bilater

No association between butyrylcholineste

No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese

✍ Lee, D.W.; Liu, H.C.; Liu, T.Y.; Chi, C.W.; Hong, C.J. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 13 KB 👁 1 views

Increased butyrylcholinesterase (BChE) activity has been reported to be associated with the formation of amyloid plaques and neurofibrillary tangles and may consequently be involved in the pathogenesis of Alzheimer disease (AD). Because the catalytic activity of BChE-K variant is reduced by one-thir

Therapy

✍ Sebastian Fitzek 📂 Fiction 📅 2013;2014 🏛 Atlantic Books Ltd;Corvus 🌐 English ⚖ 132 KB 👁 2 views